GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
This Quarter Return
-4.96%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$4.86B
AUM Growth
+$4.86B
(-7.8%)
Cap. Flow
+$65.2M
Cap. Flow
% of AUM
1.34%
Top 10 Holdings %
Top 10 Hldgs %
32.54%
Holding
208
New
15
Increased
87
Reduced
84
Closed
22
Top Buys
| 1 |
Stratasys
SSYS
|
$59.7M |
| 2 |
Life Time Group Holdings
LTH
|
$59.3M |
| 3 |
Enovix
ENVX
|
$40.6M |
| 4 |
Chegg
CHGG
|
$32M |
| 5 |
Euronet Worldwide
EEFT
|
$30.6M |
Top Sells
| 1 |
Enphase Energy
ENPH
|
$52.7M |
| 2 |
Chart Industries
GTLS
|
$46.9M |
| 3 |
Workiva
WK
|
$37M |
| 4 |
Kornit Digital
KRNT
|
$30.1M |
| 5 |
Riskified
RSKD
|
$25.7M |
Sector Composition
| 1 | Technology | 37.42% |
| 2 | Healthcare | 18.43% |
| 3 | Industrials | 16.38% |
| 4 | Consumer Discretionary | 12.45% |
| 5 | Communication Services | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Sangamo Therapeutics
SGMO
$161M
| – | – |
-348,473
| Closed | -$3.14M |
|
|
202
Riskified
RSKD
$712M
| – | – |
-1,127,069
| Closed | -$25.7M |
|
203
Protolabs
PRLB
$1.17B
| – | – |
-46,611
| Closed | -$3.1M |
|
204
Neurogene
NGNE
$284M
| – | – |
-125,331
| Closed | -$906K |
|
205
Esperion Therapeutics
ESPR
$490M
| – | – |
-293,766
| Closed | -$3.54M |
|
206
Clean Energy Fuels
CLNE
$548M
| – | – |
-670,093
| Closed | -$5.46M |
|
|
AUTL
207
Autolus Therapeutics
AUTL
$383M
| – | – |
-176,683
| Closed | -$1.16M |
|
208
Ameresco
AMRC
$1.35B
| – | – |
-142,844
| Closed | -$8.35M |
|